ANAPTYSBIO, INC: director Renton Hollings sold 5,000 shares

What happened

• The filing reports that Renton Hollings, a director, exercised options for 5,000 shares at $18.03 per share (acquired for $90,150) and sold 5,000 shares in an open-market sale at a weighted-average price of $49.87 per share (received $249,372), all on Oct 1, 2026. The filing also reports an exercise/conversion of a derivative for 5,000 shares disposed at $0.00 on Oct 1, 2026.

Key details

• Transaction dates and prices: Oct 1, 2026 — exercised 5,000 shares at $18.03; sold 5,000 shares at a weighted-average price of $49.87 (sales ranged from $49.435 to $50.37 per share); a derivative disposition of 5,000 shares at $0.00 is also reported.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnotes: the sale was made under a Rule 10b5-1 trading plan adopted Mar 30, 2026 (F1); the reported sale price is a weighted average with a disclosed price range (F2); the option is fully vested and exercisable (F3); the reporting person also holds options to purchase additional shares, including remaining options to purchase 10,000 shares and options for up to an aggregate of 92,320 shares (F4).
• Filing date: filed Oct 2, 2026 (the filing does not indicate a late report).

Why it may matter

• The filing shows exercised options and a same-day sale of shares, which is consistent with a cashless exercise where some or all exercised shares are sold immediately. A filing does not show why the insider traded or why the company acted.